Back to all Current clinical trials
Back to all Current clinical trials
RC-48
The trial is testing a potential new treatment called disitamab vedotin for Muscle-invasive Bladder Cancer.
What you need to know
Who can take part?
Patients with locally confined or Metastatic muscle invasive bladder cancer.
What is involved for you?
All patients in this trial will receive the investigational product via an IV infusion every two weeks. As part of each clinic visit, blood will be taken, a physical exam will be conducted and an ECG will be performed.
